Boston & New England CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
DivcoWest Breaks Ground on Cambridge Life Science Building
Real estate investment firm DivcoWest has broken ground on 441 Morgan Avenue, a 10-story, 375,000-square-foot life science building in the 43-acre Cambridge Crossing mixed-use neighborhood.
Future tenants at 441 Morgan Avenue, an institutional quality lab building, will join an ecosystem of innovative companies that includes Sanofi, Bristol Myers Squibb, Philips, Cerevel Therapeutics and Thrive Earlier Detection. The property will be comprised of 10 lab floors plus two penthouse floors, five outdoor terraces with stunning views, and will utilize the newest view glass technology, dynamic glass designed to create a more efficient environment that improves the well-being of those within.
“Our goal isn’t to simply create buildings, but to create an environment that supports the mission of our tenants, provides room to grow, and accelerates groundbreaking research that positively impacts lives,” said Mark Roopenian, managing director at DivcoWest. “We are proud to have broken ground at 441 Morgan Avenue, providing more opportunities for innovation to thrive, and thank all of the hardworking women and men who continue to bring CX to life everyday.”
The building is being designed by Ennead Architects with Jacobs in Boston.
- ◦Development
